Carles Vilarino-Guell, University of British Columbia

Research

Genetics Genome Sequencing Multiple Sclerosis Crc Tier 1

Latest papers

The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology.
Frontiers in neurology · 2025
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society · 2013

All 2 publications

Latest funding

Targeting inflammatory and neurodegenerative pathways relevant to progression in the NR1H3 (LXRA) R415Q model of primary progressive multiple sclerosis
CIHR · 2022 · Co-investigator
$906,526
Molecular Characterization of Multiple Sclerosis
CIHR · 2014 · Nominated PI
$420,600
CRC Tier 1
CIHR · 2012 · Nominated PI
$500,000

All 5 grants and awards

2 publications.

01

The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology.

Pagalilauan AM, Everest E, Rachimi S, Reich DS, Waldman AD, Sadovnick AD, Vilarino-Guell C, Lenardo MJ

Frontiers in neurology2025

DOI: 10.3389/fneur.2025.1509371 PMID: 40109847

02

Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.

Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J, Aasly JO, Rajput A, Rajput AH, Jon Stoessl A, Farrer MJ

Movement disorders : official journal of the Movement Disorder Society2013

DOI: 10.1002/mds.25421 PMID: 23457019

Targeting inflammatory and neurodegenerative pathways relevant to progression in the NR1H3 (LXRA) R415Q model of primary progressive multiple sclerosis

Co-investigatorCIHR2022Project Grant

Principal investigators: Quandt, Jacqueline A

Keywords: Demyelination; Experimental Autoimmune Encephalomyelitis; Multiple Sclerosis; Neurodegeneration; Neuroinflammation,; Neuroprotection; Transgenic Mice

$906,526

Molecular Characterization of Multiple Sclerosis

Nominated PICIHR2014Operating Grant

Principal investigators: Vilarino-Guell, Carles

Keywords: Genetics; Genome Sequencing; Multiple Sclerosis

$420,600

CRC Tier 1

Nominated PICIHR2012Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Vilarino-Guell, Carles

Keywords: Crc Tier 1

$500,000

Implicating Novel Genes in Familial Parkinsonism

Co-investigatorCIHR2012Operating Grant

Principal investigators: Farrer, Matthew J

Keywords: Gene Discovery; Genetics; Genome Sequencing; Neurogenetics; Parkinson Disease

$968,750

Molecular neuroscience of Parkinson's Disease: Retromer (VPS35) dysfunction

Co-investigatorCIHR2011Operating Grant

Principal investigators: Farrer, Matthew J

Keywords: Autophagy; Human Genetics; Neurogenetics; Neuroscience; Parkinson Disease; Vps35

$770,344

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Silke Appel-Cresswell

Medicine/Neurology

1 shared papers, latest 2013

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Genetics Dear Professor Vilarino-Guell, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]